Loading...
Market
Where will the initial human trials of the new HIV treatment using a molecular mimic take place by December 31, 2024?
2
Resolution / Starting Odds
United States • 25%
Europe • 25%
Asia • 25%
Other • 25%
Official announcements or publications from the research team or medical journals
Story
Scientists Develop New HIV Treatment Using Molecular Mimic, Reducing Virus 1,000-Fold
Aug 8, 2024, 08:37 PM
Scientists have developed a new experimental treatment against HIV, involving a molecular mimic that invades cells and steals essential proteins from the virus. This engineered virus, described as a 'molecular parasite', lacks the genes needed for replication, thereby using the replication machinery of wildtype HIV to crowd it out and stop it from multiplying. Promising results have been observed in monkeys, with a single shot reducing HIV levels 1,000-fold. Researchers plan to test this new therapy in a few people with HIV.
View original story
Similar markets
Yes • 50%
No • 50%
Pfizer • 25%
Johnson & Johnson • 25%
Gilead Sciences • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
United Kingdom • 25%
European Union • 25%
United States • 25%
Other • 25%
Positive impact on HIV cure • 25%
No significant impact • 25%
Negative impact • 25%
Inconclusive • 25%
USA • 25%
UK • 25%
South Africa • 25%
Other • 25%